4207 studies found for:
"Liver Diseases"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Recruiting |
Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
|
||||
| 22 | Not yet recruiting |
Study of Peripheral Tissue Oxygenation in End-stage Liver Disease Patients During Liver Transplantation
|
||||
| 23 |
Completed
Has Results |
Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease
|
||||
| 24 | Unknown † |
Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
|
||||
| 25 | Completed |
Once-Daily Oral E5501 Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
|
||||
| 26 | Not yet recruiting |
The Connection Between Liver Disease and Chitinase Proteins
|
||||
| 27 |
Completed
Has Results |
Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)
|
||||
| 28 | Recruiting |
Adult-to-Adult Living Donor Transplant Cohort Study
|
||||
| 29 | Recruiting |
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
|
||||
| 30 | Completed |
Relative-dose-response Test (RDR) Adaptation for Chronic Liver Disease
|
||||
| 31 | Completed |
Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease
|
||||
| 32 | Recruiting |
Genetic Studies of Non-Alcoholic Fatty Liver Disease
|
||||
| 33 |
Terminated
Has Results |
Polycystic Liver Disease in Kidney Transplant
|
||||
| 34 | Unknown † |
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
|
||||
| 35 | Recruiting |
Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
|
||||
| 36 | Unknown † |
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
|
||||
| 37 | Completed |
The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease
|
||||
| 38 | Completed |
Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease
|
||||
| 39 | Suspended |
Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients
|
||||
| 40 | Unknown † |
Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease
|
† Indicates status has not been verified in more than two years

